Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin...

Details Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin... Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin...

2007-05-08

2007-05-08

Qazi, Sabiha N. (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

C552S653000

Reexamination Certificate

active

10669990

ABSTRACT:
This invention provides pharmaceutical uses for 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3. Administration of this compound increases the life expectancy of human beings, especially elderly human beings. In particular, it increases the survival rate of females lacking estrogen, especially post-menopausal females, and reduces mortality resulting from spontaneous development of malignant tumors in both males and females.

REFERENCES:
patent: 5843928 (1998-12-01), DeLuca et al.

Affiliated with

Also associated with

Rating

Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3799086